Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease
✍ Scribed by Burkhard Tönshoff; Werner F. Blum; Otto Mehls
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 731 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Interest in the role of the insulin-like growth factor (IGF) axis in growth control and carcinogenesis has recently been increased by the finding of elevated serum insulin-like growth factor I (IGF-I) levels in association with three of the most prevalent cancers in the United States: prostate cance
Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulinlike growth factor I, serum levels of the high affinity growth hormone-b
## Major changes in serum levels of insulin-like growth factor After secretion from the anterior pituitary gland, growth hormone (GH) binds to specific cell-surface receptors I (IGF-I) and IGF-binding proteins (IGFBPs) occur in children with end-stage liver disease in association with changes in (